Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

January 16, 2018, Agency for Science, Technology and Research (A*STAR), Singapore

Persistent liver inflammation in sufferers of chronic viral hepatitis is likely caused by interactions between pro-inflammatory immune cells in the liver and products from gut bacteria, according to new work involving A*STAR researchers. The findings identify new therapeutic targets.

Chronic viral hepatitis is characterized by of the liver, but the mechanism that maintains this has been poorly understood. The degree of inflammation does not correspond to the extent of viral activity in the liver, or to the activity of that specifically target the virus, as might be expected.

The new work, a collaboration between the laboratories of Antonio Bertoletti at the Duke-NUS Medical and Singapore Institute of Clinical Sciences, the laboratory of Qingfeng Chen at the A*STAR Institute of Molecular and Cell Biology and Charles-Antoine Dutertre in the laboratory of Florent Ginhoux from the A*STAR Singapore Immunology Network, aimed to determine the mechanisms underpinning the inflammation. The researchers focused on a different group of immune cells called , which are increasingly recognized as significant in .

They analyzed the molecular and functional profiles of macrophages in the livers of patients with chronic viral hepatitis and those of healthy people. In the livers of patients, there was an excess of macrophages with a specific profile that promotes inflammation. "Unlike macrophages found in a healthy liver, these macrophages have the capacity to continuously produce pro-inflammatory mediators when they encounter bacterial products," explains Dutertre.

The team studied this phenomenon further in mice engineered to have human liver cells and . The mice were infected with hepatitis B virus, and consequently accumulated the same pro-inflammatory macrophage population in the liver as that seen in patients. Treatment of the mice with antibiotics to reduce the reversed the accumulation of these macrophages. "This demonstrated that bacterial products that leak from the gut into the liver are responsible for the accumulation of the pro-inflammatory macrophages," says Dutertre.

The results identify a novel mechanism that maintains inflammation in chronic viral hepatitis. Dutertre and colleagues say that their findings suggest new therapeutic approaches, in addition to targeting the virus, that involve modifying the intestinal bacteria or depleting the pro-inflammatory macrophages in the liver.

The researchers are now investigating the mechanism behind the effects of bacterial products on macrophages in the liver. So far they have identified certain soluble mediators that play a pivotal role. "Our hypothesis is that by inhibiting these soluble mediators, we could limit the accumulation of the pro-inflammatory macrophages and resolve inflammation in patients with chronic viral hepatitis," concludes Dutertre.

Explore further: Zinc may hold key to fighting liver disease

More information: Alfonso Tan-Garcia et al. Intrahepatic CD206 + macrophages contribute to inflammation in advanced viral-related liver disease, Journal of Hepatology (2017). DOI: 10.1016/j.jhep.2017.04.023

Related Stories

Zinc may hold key to fighting liver disease

June 1, 2017
New research from the Westmead Institute's Storr Liver Centre in collaboration with the Centre for Virus Research and Kirby Institute has shown that serum zinc may benefit liver disease in a way we never expected.

Role of transcriptional co-factor hints at possible inflammatory bowel disease treatment

December 12, 2017
Inflammatory bowel disease (IBD), including the two conditions ulcerative colitis and Crohn's disease, results in long-term inflammation of the gut and is associated with dysregulation of the immune system. However, it is ...

A new mechanism protecting the liver from dangerous inflammation

May 28, 2015
Life-threatening liver inflammation can be caused by excess alcohol, fatty foods, toxins, as well as viral, bacterial, and parasite infections. A study published on May 28th in PLOS Pathogens reports that a specific immune ...

New test can predict death in patients with serious liver disease

April 1, 2016
Acute-on-chronic liver failure (ACLF) is a sudden deterioration of the liver function in a patient with liver cirrhosis accompanied by failure of one or more organ systems. This liver disease has a serious prognosis and the ...

Study finds molecules present possible biomarkers of HCV-related liver damage progression

October 25, 2017
Hepatitis C virus infection leads to a wide spectrum of liver diseases ranging from mild chronic hepatitis to end-stage cirrhosis and hepatocellular carcinoma. An intriguing aspect of the HCV infection is its close connection ...

Inflammatory signature of nonalcoholic fatty liver disease

May 16, 2017
A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease. Current treatment for the disorder involves changes ...

Recommended for you

Targeting sepsis, the leading cause of ICU deaths, with a nanocarrier-delivered microRNA

December 3, 2018
One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an estimated price tag of $20 ...

Cells using sugar for metabolic process may fight inflammation

November 27, 2018
New research by a team from the FAMU-FSU College of Engineering has discovered that a type of adult stem cell found in a variety of tissues can be manipulated to enhance tissue regeneration and potentially treat inflammatory ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.